Mohammad A. Khanfar
Al Takhassusi Rd
Riyadh, 11533, Saudi Arabia
Riyadh, 11533, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Integrated chemometric modelling of histamine H3 receptor for the identification of ligands from a natural product repository.
Journal: SAR and QSAR in environmental research
Published: April 27, 2026
Unrevealing the Wound Healing Involvement of TGF-β/VEGF Signaling of Tamarix Honey-Derived Chlorogenic Acid in 1H NMR Metabolomics, In Vivo, and In Silico Studies.
Journal: Chemistry & biodiversity
Published: March 25, 2025
Innovative buccal film delivery system for hypertension: Combining candesartan and hydrochlorothiazide.
Journal: Journal of biomaterials applications
Published: February 01, 2025
Design and synthesis of 3-(azepan-1-ylsulfonyl)-N-aryl benzamide derivatives as potent carbonic anhydrase IX inhibitors with anticancer activities.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences
Published: October 14, 2024
Virtual Screening Identifies Inhibitors of SARS-CoV-2 Main Protease through Pharmacophore and Similarity Approaches.
Journal: Current pharmaceutical design
Published: October 03, 2024
Artificial intelligence in healthcare education: evaluating the accuracy of ChatGPT, Copilot, and Google Gemini in cardiovascular pharmacology.
Journal: Frontiers in medicine
Published: September 12, 2024
Histamine H3 receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 03, 2024
Design and Synthesis of 3-(Phenylsulfonamido)benzamide Derivatives as Potent Carbonic Anhydrase IX Inhibitors: Biological Evaluations and Molecular Modeling Studies.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: May 09, 2024
SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections.
Journal: Current medicinal chemistry
Published: July 11, 2023
Discovery of natural-derived Mpro inhibitors as therapeutic candidates for COVID-19: Structure-based pharmacophore screening combined with QSAR analysis.
Journal: Molecular informatics
Published: December 26, 2022
Synthesis and Biological Evaluation of Thiazole-based Fibroblast Growth Factor Receptor-1 Inhibitors.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 12, 2022
Last Updated: 09/26/2026